An Implicit Message for the Toxic Tort Litigation Industry News – Tripled Profits for Illumina

Need more proof that the future of toxic torts will involve molecular issues? Consider that the impact of gene sequencing shows up in multiple places, including hospitals and on Wall Street. Illumina is one of two companies leading production of computerized systems for gene sequencing, and is the clear leader. Business is so good that Illumina  just announced tripled profits, and blew well past analyst expectations. Last spring, the MIT Technology Review named Illumina the “smartest company in the world.”